These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10066096)

  • 1. The significance of the expression of tumor suppressor gene DCC in human gliomas.
    Nakatani K; Yoshimi N; Mori H; Sakai H; Shinoda J; Andoh T; Sakai N
    J Neurooncol; 1998 Dec; 40(3):237-42. PubMed ID: 10066096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
    Bamias AT; Bai MC; Agnantis NJ; Michael MC; Alamanos YP; Stefanaki SV; Razi ED; Skarlos DV; Kappas AM; Pavlidis NA
    Cancer Invest; 2003 Jun; 21(3):333-40. PubMed ID: 12901278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significant role of telomerase activity in human brain tumors.
    Nakatani K; Yoshimi N; Mori H; Yoshimura S; Sakai H; Shinoda J; Sakai N
    Cancer; 1997 Aug; 80(3):471-6. PubMed ID: 9241081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival.
    Zhou YH; Tan F; Hess KR; Yung WK
    Clin Cancer Res; 2003 Aug; 9(9):3369-75. PubMed ID: 12960124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of JAM-A in gliomas.
    Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
    J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent reduction or loss of DCC gene expression in human osteosarcoma.
    Horstmann MA; Pösl M; Scholz RB; Anderegg B; Simon P; Baumgaertl K; Delling G; Kabisch H
    Br J Cancer; 1997; 75(9):1309-17. PubMed ID: 9155051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.
    Kirla R; Salminen E; Huhtala S; Nuutinen J; Talve L; Haapasalo H; Kalimo H
    J Neurooncol; 2000; 46(1):71-80. PubMed ID: 10896207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the tumor suppressor gene DCC in human gliomas.
    Scheck AC; Coons SW
    Cancer Res; 1993 Dec; 53(23):5605-9. PubMed ID: 8242611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
    Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry.
    Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.